RE:Incorrect design trialEvery word you are stating Francine - I agree with 100%.
The BOD had the chance to flush Jan out last year but Haywood came to her rescue (don't know why?). We are stuck with her incompetence and evasiveness now...she just wasted 6 monhts of shareholder's valuable time leaving us in the dark. And it is incompetence because it doesn't take a doctor to know that severe diet reduces TG. A simple medical technician knows that! Jan is aware EXACTLY what happened during Trilogy 1 and that's why an outside expert was hired to she can save her behind. Today, she um'ed and aw'ed her way through the conference call, acted stupid (on purpose) and pleaded innocence: that's what negligent CEOs do when they screw up (not take the blame and not own their mistake).
CAPRE is a "blockbuster drug" and we have to use Jan's incompetence to average down here. I see this as a gift. Trilogy 2 might have the same effect but to a much lesser extent and it should drive the NDA to the finish line rather easily based on my study of the data. Jan knows this very well but can't announce it freely to the world without the unblinding.
Added more today and I have some dry powder to keep adding even more. I can see this as a 10 bagger from these levels.
Trilogy 2 will make it for us and if Jan is booted in the interim or right after the NDA, that will give the stock an even further boost.